TARRYTOWN, N.Y. — Siemens Healthineers reported today it has achieved 12 Pre-Market Approvals from the Food and Drug Administration for its infectious disease and oncology testing menu. This milestone means the company’s Atellica® Solution1 now provides laboratories in the U.S. with a comprehensive menu on a single laboratory platform for patients’ in vitro diagnostic testing